Correlation Between Biogen and Astellas Pharma

Can any of the company-specific risk be diversified away by investing in both Biogen and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biogen and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biogen Inc and Astellas Pharma, you can compare the effects of market volatilities on Biogen and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biogen with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biogen and Astellas Pharma.

Diversification Opportunities for Biogen and Astellas Pharma

0.94

Correlation Coefficient

Biogen  Astellas Pharma

Almost no diversification

The 3 months correlation between Biogen and Astellas is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding Biogen Inc and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Biogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biogen Inc are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Biogen i.e., Biogen and Astellas Pharma go up and down completely randomly.

Pair Corralation between Biogen and Astellas Pharma

Given the investment horizon of 90 days Biogen Inc is expected to under-perform the Astellas Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Biogen Inc is 1.16 times less risky than Astellas Pharma. The stock trades about -0.26 of its potential returns per unit of risk. The Astellas Pharma is currently generating about -0.2 of returns per unit of risk over similar time horizon. If you would invest  1,171  in Astellas Pharma on October 11, 2024 and sell it today you would lose (217.00) from holding Astellas Pharma or give up 18.53% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Biogen Inc  vs.  Astellas Pharma

Biogen Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biogen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Astellas Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Biogen and Astellas Pharma

The main advantage of trading using opposite Biogen and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biogen position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.

The idea behind Biogen Inc and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.